Calviri

Tempe, United States

Calviri provides cancer treatment products by combining the immunogenic source of neoantigens with a peptide array platform.

$785K raised

Nov 2024

Undisclosed

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Calviri raised?

Calviri has raised $785K in total funding. The most recent round was Undisclosed. The last funding was announced in November 2024.

Who are Calviri's investors?

Calviri's investors include Mitzi Krockover, Jacque J. Sokolov.

Where is Calviri headquartered?

Calviri is headquartered in Tempe, United States.

What does Calviri do?

Calviri provides cancer treatment products by combining the immunogenic source of neoantigens with a peptide array platform.

What stage is Calviri at?

Calviri is at the Undisclosed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 8, 2024.

MLA

"Calviri — Funding & Investors." VCBacked, November 8, 2024, https://www.vcbacked.co/company/calviri. Accessed July 2, 2026.

APA

VCBacked. (2024). Calviri — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/calviri

Wikipedia (cite web)

{{cite web |title=Calviri — Funding & Investors |url=https://www.vcbacked.co/company/calviri |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 8, 2024.